OpenAlex | Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021

Work

Year: 2022

Type: article

Abstract: On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the adenovirus-vectored COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical c... more

Source: MMWR Morbidity and Mortality Weekly Report

Authors Sara E. Oliver, Megan Wallace, Isaac See, Sarah Mbaeyi, Monica Godfrey +19 more

Cites: 12

Cited by: 92

Related to: 10

FWCI: 29.68

Citation percentile (by year/subfield): 100

Topic: Heparin-Induced Thrombocytopenia and Thrombosis

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

Sustainable Development Goal Good health and well-being

Open Access status: gold